Patients Streamlining post-trial treatment access for rare disease pa... Companies have a practical and ethical responsibility to continue treating patients when clinical trial data collection ends mid-trial.
Patients Why inclusive engagement is key to closing health gaps Over the summer, the People Centric Advocacy Model (PCAM) launched, a new approach to tackling health inequalities.
Patients FH25: On patient access and equity, with Roberta Sarno In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with founder, director, and global health advisor.
Patients Strengthening safety: The critical role of reliable labellin... Learn more about the important role that labelling plays within pharmaceutical labelling and across blood transfusions.
Patients FH25: Exploring the intersection of patients, HCPs, and tech... In a new FH25 podcast, Denise Silber, founder of Basil Strategies and Doctors 2.0, discusses the intersection of HCPs, patients, and technology.
Patients Reimagining VLU and DFU management: Why speed matters in chr... Chronic wounds, particularly venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs), represent a persistent and growing challenge in healthcare.
News Major trial launched to explore GLP-1 benefit in dementia A $100m trial has been launched to see if lifestyle changes coupled with GLP-1 agonists or similar incretins can reduce the risk of dementia.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.